certolizumab pegol

Certolizumab pegol is a medication used to treat autoimmune conditions, such as rheumatoid arthritis, Crohn's disease, and psoriasis. It works by blocking a specific protein in the immune system called tumor necrosis factor (TNF), which contributes to inflammation and joint damage. By reducing this inflammation, certolizumab can help alleviate symptoms, improve physical function, and enhance the quality of life for patients. It's usually administered through an injection under the skin and is part of a class of drugs known as biologics, which are engineered from living cells to target specific pathways in the immune system.